Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122306002 | 12230600 | 2 | F | 20160213 | 20160617 | 20160401 | 20160704 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-114027 | RANBAXY | 82.00 | YR | F | Y | 0.00000 | 20160704 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122306002 | 12230600 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | RECEIVED TWO DOSES (TWO TABLETS ) ON 13-FEB | U | 75747 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122306002 | 12230600 | 1 | Cystitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122306002 | 12230600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122306002 | 12230600 | Diarrhoea | |
| 122306002 | 12230600 | Erythema | |
| 122306002 | 12230600 | Myalgia | |
| 122306002 | 12230600 | Paraesthesia | |
| 122306002 | 12230600 | Rash macular | |
| 122306002 | 12230600 | Rash pruritic | |
| 122306002 | 12230600 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122306002 | 12230600 | 1 | 20160213 | 0 |